March 2023 ProMIS Neurosciences Overview Targeting Misfolded Proteins in Neurodegenerative Diseases NASDAQ: PMN Toronto Stock Exchange (TSX): PMN.TO 1 Legal Disclaimers This ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From To Commission file number: 001-41429 PROMIS NEUROSCIENCES INC. (Exact name of registrant as specified in its charter) Canada 98-0647155 (State of Other Juri ...

| --- | --- | --- | --- | --- | --- | --- | |-------|-------|--------|-------|-------|-------|-------| | | | ProMIS | Neurosciences: HC Wainwright Conference | | | | | | | | | | | | | | | | | | | | | | | | | | Toronto Stock Exchange (TSX) ticker: PMN September 2019 | | | | | OTCQB ticker: ARFXF | | | | 1 | Forward looking statement: safe harbor This slide deck may contain certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause ac ...